Mesenchymal Stem Cell-Based Immunomodulation: Properties and Clinical Application

Table 3

Clinical trials using mesenchymal stem cells (registered as of October 26, 2017).

Indication	Number of studies
Immunomodulation	105
Multiple sclerosis/atherosclerosis	31
Type 1 diabetes	18
Crohn’s disease	22
Systemic lupus (erythematosus/colitis)	11
Rheumatoid arthritis/Sjögren’s syndrome	7
Buerger’s disease/sickle cell disease	3
HIV	2
Limbus corneae insufficiency syndrome	1
Periodontitis	5
Progressive hemifacial atrophy	2
Retinitis pigmentosa	3
Graft enhancement	44
GvHD	41
Hematopoietic malignancies	3

All values have been extracted from https://clinicaltrials.gov/.